» Articles » PMID: 35833273

Reactive Oxygen Species Scavenging Functional Hydrogel Delivers Procyanidins for the Treatment of Traumatic Brain Injury in Mice

Overview
Date 2022 Jul 14
PMID 35833273
Authors
Affiliations
Soon will be listed here.
Abstract

Traumatic brain injury (TBI) is accompanied by the overload of reactive oxygen species (ROS), which can result in secondary brain injury. Although procyanidins (PCs) have a powerful free radical scavenging capability and have been widely studied in the treatment of TBI, conventional systemic drug therapy cannot make the drug reach the targeted area in the early stage of TBI and will cause systemic side effects because of the presence of the blood-brain barrier (BBB). To address this tissue, we designed and fabricated a ROS-scavenging functional hydrogel loaded PC (GelMA-PPS/PC) to deliver the drug by responding to the traumatic microenvironment. injection of the GelMA-PPS/PC hydrogel effectively avoided the BBB and was directly applied to the surface of brain tissue to target the traumatic area. Hydrophobic poly(propylene sulfide) (PPS), an ROS quencher and HO-responsive substance, was covalently bound to GelMA and exposed in response to the trauma microenvironment. At the same time, the HO response of PPS further caused the structure of the hydrogel to degrade and release the encapsulated PC. Then PC could regulate the oxidative stress response in the cells and synergistically deplete ROS to play a neurotrophic protective role. This work suggests a novel method for the treatment of secondary brain injury by inhibiting the oxidative stress response after TBI.

Citing Articles

Applications of hydrogels and nanoparticles in the treatment of traumatic brain injury.

Shi J, Tang J, Xu J, Jiang N, Yang Y, Chen H Front Bioeng Biotechnol. 2025; 12():1515164.

PMID: 39834632 PMC: 11743581. DOI: 10.3389/fbioe.2024.1515164.


A reactive oxygen species-responsive hydrogel loaded with Apelin-13 promotes the repair of spinal cord injury by regulating macrophage M1/M2 polarization and neuroinflammation.

Li Z, Zhao Q, Zhou J, Li Y, Zheng Y, Chen L J Nanobiotechnology. 2025; 23(1):12.

PMID: 39794784 PMC: 11724542. DOI: 10.1186/s12951-024-02978-4.


Hydrogel in the Treatment of Traumatic Brain Injury.

Li S, Xu J, Qian Y, Zhang R Biomater Res. 2024; 28:0085.

PMID: 39328790 PMC: 11425593. DOI: 10.34133/bmr.0085.


Application of stimuli-responsive hydrogel in brain disease treatment.

Xie B, Xie H Front Bioeng Biotechnol. 2024; 12:1450267.

PMID: 39091971 PMC: 11291207. DOI: 10.3389/fbioe.2024.1450267.


Immune-mediated disruption of the blood-brain barrier after intracerebral hemorrhage: Insights and potential therapeutic targets.

Jia P, Peng Q, Fan X, Zhang Y, Xu H, Li J CNS Neurosci Ther. 2024; 30(7):e14853.

PMID: 39034473 PMC: 11260770. DOI: 10.1111/cns.14853.